M & L Capital Management Ltd Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

M & L Capital Management Ltd purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,700 shares of the medical equipment provider’s stock, valued at approximately $9,239,000. Intuitive Surgical comprises approximately 2.3% of M & L Capital Management Ltd’s holdings, making the stock its 10th largest position.

A number of other large investors have also recently bought and sold shares of ISRG. Bennett Selby Investments LP increased its stake in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares during the period. Onefund LLC raised its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC boosted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its stake in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its position in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.6 %

Shares of Intuitive Surgical stock opened at $484.44 on Friday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $172.55 billion, a price-to-earnings ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average is $567.46 and its 200 day moving average is $531.26.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ISRG shares. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.